Analysts think HAE stock price could increase by 31%
Jul 30, 2024, 6:25 AM
-14.49%
What does HAE do
Haemonetics Corp., headquartered in Boston, Massachusetts, develops and distributes hematology products, serving blood and plasma collection, surgical, and hospital transfusion markets with 3,034 employees. The company's offerings include automated systems, donor software, and solutions enhancing patient care and reducing healthcare costs across its Plasma, Blood Center, and Hospital segments.
8 analysts think HAE stock price will increase by 30.78%. The current median analyst target is $117.30 compared to a current stock price of $89.69. The lowest analysts target is $94.94 and the highest analyst target is $131.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
